We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDAnews Webinar Highlights Drawbacks to Remote Inspections
FDAnews Webinar Highlights Drawbacks to Remote Inspections
An FDA remote inspection can carry major drawbacks, including that they may last longer than an in-person visit and that the FDA doesn’t consider them to be a full substitute for an on-site inspection.